Cargando…
Olfactory Reference Syndrome (Halitophobia) With Oral Cenesthopathy Treated With Low-Dose Aripiprazole: A Case Report
INTRODUCTION: Olfactory reference syndrome (ORS) (halitophobia) is the excessive fear of having bad breath without clinical findings supporting the patient's complaints. In this case report, a low dose of aripiprazole (ARP) successfully improved oral cenesthopathy and then improved ORS. CASE PR...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594496/ https://www.ncbi.nlm.nih.gov/pubmed/34538856 http://dx.doi.org/10.1097/WNF.0000000000000476 |
_version_ | 1784600004676026368 |
---|---|
author | Takenoshita, Miho Motomura, Haruhiko Toyofuku, Akira |
author_facet | Takenoshita, Miho Motomura, Haruhiko Toyofuku, Akira |
author_sort | Takenoshita, Miho |
collection | PubMed |
description | INTRODUCTION: Olfactory reference syndrome (ORS) (halitophobia) is the excessive fear of having bad breath without clinical findings supporting the patient's complaints. In this case report, a low dose of aripiprazole (ARP) successfully improved oral cenesthopathy and then improved ORS. CASE PRESENTATION: A 44-year-old female patient complained of a sensation of astringent film sticking on her tongue. She was also very anxious about her bad breath at work. We prescribed 0.5 mg of ARP for her symptoms because she worried about potential drowsiness. One week later, the patient reported that the oral sensation had resolved 2 to 3 days after the mediation was administered. No obvious adverse effects were observed except temporary arousal during sleep. Three months after the initial visit, her symptoms worsened, partly because of her job change, so we increased the dose of ARP from 0.5 mg to 1 mg. Later, the patient reported that she was better able to manage the anxiety about her breath. At the 2-year follow-up, her symptoms have continued to improve without medication. CONCLUSIONS: Although the most effective approach to ORS is not established, the current study indicates that a low dose of ARP to treat oral cenesthopathy might improve ORS. |
format | Online Article Text |
id | pubmed-8594496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-85944962021-11-19 Olfactory Reference Syndrome (Halitophobia) With Oral Cenesthopathy Treated With Low-Dose Aripiprazole: A Case Report Takenoshita, Miho Motomura, Haruhiko Toyofuku, Akira Clin Neuropharmacol Case Reports INTRODUCTION: Olfactory reference syndrome (ORS) (halitophobia) is the excessive fear of having bad breath without clinical findings supporting the patient's complaints. In this case report, a low dose of aripiprazole (ARP) successfully improved oral cenesthopathy and then improved ORS. CASE PRESENTATION: A 44-year-old female patient complained of a sensation of astringent film sticking on her tongue. She was also very anxious about her bad breath at work. We prescribed 0.5 mg of ARP for her symptoms because she worried about potential drowsiness. One week later, the patient reported that the oral sensation had resolved 2 to 3 days after the mediation was administered. No obvious adverse effects were observed except temporary arousal during sleep. Three months after the initial visit, her symptoms worsened, partly because of her job change, so we increased the dose of ARP from 0.5 mg to 1 mg. Later, the patient reported that she was better able to manage the anxiety about her breath. At the 2-year follow-up, her symptoms have continued to improve without medication. CONCLUSIONS: Although the most effective approach to ORS is not established, the current study indicates that a low dose of ARP to treat oral cenesthopathy might improve ORS. Lippincott Williams & Wilkins 2021 2021-09-20 /pmc/articles/PMC8594496/ /pubmed/34538856 http://dx.doi.org/10.1097/WNF.0000000000000476 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Case Reports Takenoshita, Miho Motomura, Haruhiko Toyofuku, Akira Olfactory Reference Syndrome (Halitophobia) With Oral Cenesthopathy Treated With Low-Dose Aripiprazole: A Case Report |
title | Olfactory Reference Syndrome (Halitophobia) With Oral Cenesthopathy Treated With Low-Dose Aripiprazole: A Case Report |
title_full | Olfactory Reference Syndrome (Halitophobia) With Oral Cenesthopathy Treated With Low-Dose Aripiprazole: A Case Report |
title_fullStr | Olfactory Reference Syndrome (Halitophobia) With Oral Cenesthopathy Treated With Low-Dose Aripiprazole: A Case Report |
title_full_unstemmed | Olfactory Reference Syndrome (Halitophobia) With Oral Cenesthopathy Treated With Low-Dose Aripiprazole: A Case Report |
title_short | Olfactory Reference Syndrome (Halitophobia) With Oral Cenesthopathy Treated With Low-Dose Aripiprazole: A Case Report |
title_sort | olfactory reference syndrome (halitophobia) with oral cenesthopathy treated with low-dose aripiprazole: a case report |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594496/ https://www.ncbi.nlm.nih.gov/pubmed/34538856 http://dx.doi.org/10.1097/WNF.0000000000000476 |
work_keys_str_mv | AT takenoshitamiho olfactoryreferencesyndromehalitophobiawithoralcenesthopathytreatedwithlowdosearipiprazoleacasereport AT motomuraharuhiko olfactoryreferencesyndromehalitophobiawithoralcenesthopathytreatedwithlowdosearipiprazoleacasereport AT toyofukuakira olfactoryreferencesyndromehalitophobiawithoralcenesthopathytreatedwithlowdosearipiprazoleacasereport |